Venus Medtech (Hangzhou) (HKSE:02500) PB Ratio : 0.78 (As of May. 23, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Venus Medtech (Hangzhou) PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-23), Venus Medtech (Hangzhou)'s share price is HK$5.62. Venus Medtech (Hangzhou)'s Book Value per Share for the quarter that ended in Dec. 2023 was HK$7.24. Hence, Venus Medtech (Hangzhou)'s PB Ratio of today is 0.78.

The historical rank and industry rank for Venus Medtech (Hangzhou)'s PB Ratio or its related term are showing as below:

HKSE:02500' s PB Ratio Range Over the Past 10 Years
Min: 0.45 Med: 1.86 Max: 30.22
Current: 0.78

During the past 7 years, Venus Medtech (Hangzhou)'s highest PB Ratio was 30.22. The lowest was 0.45. And the median was 1.86.

HKSE:02500's PB Ratio is ranked better than
86.6% of 791 companies
in the Medical Devices & Instruments industry
Industry Median: 2.23 vs HKSE:02500: 0.78

During the past 12 months, Venus Medtech (Hangzhou)'s average Book Value Per Share Growth Rate was -20.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -12.20% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 28.90% per year.

During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Venus Medtech (Hangzhou) was 266.10% per year. The lowest was -12.20% per year. And the median was 57.20% per year.

Back to Basics: PB Ratio

Venus Medtech (Hangzhou) PB Ratio Historical Data

The historical data trend for Venus Medtech (Hangzhou)'s PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Venus Medtech (Hangzhou) PB Ratio Chart

Venus Medtech (Hangzhou) Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

PB Ratio

Get a 7-Day Free Trial

4.49

7.40

2.35

1.56

0.78

Venus Medtech (Hangzhou) Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
PB Ratio	Get a 7-Day Free Trial							2.35	1.49	1.56	0.75	0.78

Competitive Comparison of Venus Medtech (Hangzhou)'s PB Ratio

For the Medical Devices subindustry, Venus Medtech (Hangzhou)'s PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Venus Medtech (Hangzhou)'s PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Venus Medtech (Hangzhou)'s PB Ratio distribution charts can be found below:

* The bar in red indicates where Venus Medtech (Hangzhou)'s PB Ratio falls into.

Venus Medtech (Hangzhou) PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Venus Medtech (Hangzhou)'s PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Dec. 2023)
	=	5.62	/	7.244
	=	0.78

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Venus Medtech (Hangzhou) (HKSE:02500) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Venus Medtech (Hangzhou) PB Ratio Related Terms

Thank you for viewing the detailed overview of Venus Medtech (Hangzhou)'s PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Venus Medtech (Hangzhou) (HKSE:02500) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Venus Medtech (Hangzhou) Inc (HKSE:02500) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

VMTHF:USA

Address

No. 88, Jiangling Road, Room 311, 3rd Floor, Block 2, Binjiang District, Hangzhou, CHN, 310051

Website

https://www.venusmedtech.com

Venus Medtech (Hangzhou) Inc is engaged in the development and commercialization of transcatheter solutions for structural heart diseases. It has two TAVR products on the market, namely VenusA-Valve, and VenusA-Plus. VenusA-Valve is its first-generation TAVR device, which is used to treat severe Aortic Stenosis (AS) using a transcatheter approach. VenusA-Plus is an upgraded product of VenusA-Valve. Geographically all of the revenue is derived from Mainland China.

Venus Medtech (Hangzhou) (HKSE:02500) Headlines

No Headlines